Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells

Stem Cells

Volumn 25, Issue 5, 2007, Pages 1119-1125

  Giuntoli, Serena ^a   Rovida, Elisabetta ^a   Gozzini, Antonella ^b   Barbetti, Valentina ^a   Cipolleschi, Maria Grazia ^a   Olivotto, Massimo ^a   Sbarba, Persio Dello ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Divisione di Ematologia   (Italy)

^c Dipartimento di Patologia e Oncologia Sperimentali   (Italy)

Author keywords

5 fluorouracil resistance; Culture repopulating ability; Leukemia stem cells; Severe hypoxia

Indexed keywords

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; ERYTHROLEUKEMIA CELL; HEMATOPOIESIS; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; STEM CELL;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL HYPOXIA; CELL LINE, TUMOR; CLONE CELLS; COLONY-FORMING UNITS ASSAY; FLUOROURACIL; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; TUMOR STEM CELLS;

MURINAE;

EID: 34247565990     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0637     Document Type: Article

References (20)

1. Cipolleschi MG, Dello Sbarba P, Olivotto M. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 1993;82:2031-2037.
2. Cipolleschi MG, Rovida E, Ivanović Z et al. The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. Leukemia 2000;14:735-739.
3. Ivanović Z, Dello Sbarba P, Trimoreau F et al. Primitive human HPCs are better maintained and expanded in vitro at 1 percent than 20 percent oxygen. Transfusion 2000;40:1482-1488.
4. Ivanović Z, Bartolozzi B, Bernabei PA et al. Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br J Haematol 2000;108:424-429.
5. Ivanović Z, Belloc F, Faucher JL et al. Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells. Exp Hematol 2002;30:67-73.
6. Danet GH, Pan Y, Luongo JL et al. Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest 2003;112:126-135.
7. Ivanovic Z, Hermitte F, Brunet de la Grange P et al. Simultaneous maintenance of human cord blood SCID-repopulating cells and expansion of committed progenitors at low O2 concentration (3%). STEM CELLS 2004;22:716-724.
8. Lotem J, Sachs L. Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin Cancer Biol 2002;12:339-346.
9. Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res 1996;56:5754-5757.
10. Jensen PO, Mortensen BT, Hodgkiss RJ et al. Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukemia in rats. Cell Prolif 2000;33:381-395.
11. Desplat V, Faucher JL, Mahon FX et al. Hypoxia modifies proliferation and differentiation of CD34(+) CML cells. STEM CELLS 2002;20:347-354.
12. Giuntoli S, Rovida E, Barbetti V et al. Hypoxia suppresses BCR/Abl and selects Imatinib-insensitive progenitors within clonal CML populations. Leukemia 2006;20:1291-1293.
13. 2 concentration (0.1%) favors G0 return of dividing CD34+ cells. STEM CELLS 2006;24:65-73.
14. Reya T, Morrison SJ, Clarke MF et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
15. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004;23:7274-7282.
16. Warner JK, Wang JC, Hope KJ et al. Concepts of human leukemic development. Oncogene 2004;23:7164-7177.
17. Jordan CT, Guzman ML. Mechanisms controlling pathogenesis and survival of leukemic stem cells. Oncogene 2004;23:7178-7187.
18. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.
19. Blagosklonny MV. Antiangiogenic therapy and tumor progression. Cancer Cell 2004;5:13-17.
20. Blagosklonny MV. Target for cancer therapy: proliferating cells or stem cells. Leukemia 2006;20:385-391.